Scott Sandler
VICE PRESIDENT, FINANCE
Management
Oxford BioTherapeutics
Spain
Biography
Mr Sandler brings over 20 years of financial experience in the biotechnology industry to OBT. Most recently, he was Senior Director at Hyperion Therapeutics, a pharmaceutical company focussed on therapies for orphan diseases. Previously, he has held financial roles at Ipsen, Nektar Therapeutics and Genentech. Mr. Sandler holds an BSE in engineering from Tufts University and an MBA from the University of Michigan.
Research Interest
Orphan diseases
